Gilteritinib is an orally administered, second generation, highly selective type I FLT3 inhibitor with potent activity against both FLT3 subtypes (ITD and TKD). It also inhibits several other kinases, including AXL, which has been implicated in FLT3 inhibitor resistance, c-KIT, and anaplastic lymphoma kinase (ALK).
Additional Information
Payment Terms T/TWestern Union
Interested in this product? Ask for more details & Latest Price from seller
Member Since 8 Years
Nature of Business Exporter
GST No. 33ACGPF5198L1ZB
For Buyer 
For Seller 
Help 
Virugambakkam, Chennai, Tamil Nadu 
Send Enquiry